Mickaël Hiligsmann (M.J.C.)

Agh, T., Borah, B., Vervloet, M., & Hiligsmann, M. (2026). Medication adherence research: expert perspectives on key HEOR trends for 2026. Expert Review of Pharmacoeconomics & Outcomes Research, 26(4), 469-471. https://doi.org/10.1080/14737167.2026.2650160

Chandran, M., Reginster, J.-Y., Kim, M.-Y., & Hiligsmann, M. (2026). Clinical and economic impact of deep learning-enhanced opportunistic osteoporosis screening using chest radiographs with and without the osteoporosis self-assessment tool for Asians (OSTA). Osteoporosis International, 37(3), 717-726. https://doi.org/10.1007/s00198-026-07858-1

Dalhuisen, I., Wurkum, M., Bervoets, C., Constant, E., van Exel, E., Hiligsmann, M., Sack, A., Schuhmann, T., Tendolkar, I., Verplancke, T., Wijnen, B., Baeken, C., & van Eijndhoven, P. (2026). Enhancing effect of cognitive control training on rTMS treatment in depression: A study protocol for a multicenter randomized controlled trial. Contemporary Clinical Trials, 161, Article 108212. https://doi.org/10.1016/j.cct.2025.108212

Hiligsmann, M., Kong, S. H., Alokail, M., Kim, M.-Y., & Reginster, J.-Y. (2026). Evaluating the cost-effectiveness of artificial intelligence-enhanced osteoporosis screening in men and women using routine chest radiographs in South Korea. JBMR plus, 10(2), Article ziaf187. https://doi.org/10.1093/jbmrpl/ziaf187

Wiethoff, I., Witlox, W. J. A., Evers, S. M. A. A., Michels, M., & Hiligsmann, M. (2026). Model-Based Economic Evaluation of the First-in-Class Myosin Inhibitor Mavacamten Versus Care as Usual in Obstructive Hypertrophic Cardiomyopathy Patients from a Dutch Societal Perspective. Pharmacoeconomics, 44(2), 245-259. https://doi.org/10.1007/s40273-025-01564-2

Maas, L., Contreras-Meca, C., Ghezzo, S., Belmans, F., Corsi, A., Cant, J., Vos, W., Bobowicz, M., Rygusik, M., Wysocki, P. T., Weiss, M. E. R., Neri, E., Caputo, F. P., Franceschello, R., Fanni, S. C., Annemans, L., & Hiligsmann, M. (2026). Cost-effectiveness analysis of artificial intelligence (AI) for response prediction of neoadjuvant radio(chemo)therapy in locally advanced rectal cancer (LARC) in the Netherlands. Expert Review of Pharmacoeconomics & Outcomes Research, 26(2), 303-312. https://doi.org/10.1080/14737167.2026.2615683

Li, N., Rambod, B., Dukers-Muijrers, N., Chevalier, J. M., Steijvers, L., Kojan, L., Wijnen, S., Crutzen, R., Jahn, B., Siebert, U., Stellbrink, L., Van Daalen, F., Kretzschmar, M., & Hiligsmann, M. (2026). General population preferences for health-related protective behaviors during infectious disease emergencies: a systematic review of conjoint-analysis studies. Social Science & Medicine, 388, Article 118721. https://doi.org/10.1016/j.socscimed.2025.118721

Heggen, B. D. C., Chesnaye, N. C., Dekker, F. W., van Diepen, M., Rotmans, J. I., Caskey, F. J., Torino, C., Vilasi, A., Szymczak, M., Drechsler, C., Wanner, C., Pippias, M., Jager, K. J., Evans, M., Hiligsmann, M., Schurink, G. W. H., Snoeijs, M. G. J., & EQUAL study investigators (2026). Vascular Access Surgery Timing: A Prospective European Cohort Study in Elderly Patients with ESKD. Kidney360. Advance online publication. https://doi.org/10.34067/KID.0000001180

Iskandar, K., Roques, C., Salameh, P., Rizk, R., Daham, J., Hiligsmann, M., Karam, R., & Molinier, L. (2026). Economics perspectives on understanding antimicrobial use and resistance: a scoping review from theory to practice. Expert Review of Pharmacoeconomics & Outcomes Research, 26(1), 33-52. https://doi.org/10.1080/14737167.2025.2591291

Heinz, K. C., Beaudart, C., De Greef, A., Vanhooteghem, O., Gostynski, A., & Hiligsmann, M. (2026). Patients' preferences for atopic dermatitis treatments in Europe: a discrete choice experiment. Expert Review of Pharmacoeconomics & Outcomes Research, 26(1), 131-138. https://doi.org/10.1080/14737167.2025.2594633